12th Annual QNova Partnering Forum
at JP Morgan Healthcare Week

About the JP Morgan Partnering Forum

On January 12-15, 2026, MedTech World partners with QNova LifeSciences to co-host the 12th Annual Partnering Forum during JP Morgan Healthcare Week at the Hilton San Francisco Union Square. This hybrid event offers in-person networking in San Francisco followed by virtual sessions on February 4-5, providing a premier platform for life science companies, investors, service providers, and government officials to forge strategic alliances.

As an invite-only gathering, the forum is limited to key decision-makers and focuses on advancing drugs, medical devices, and technologies from discovery to commercialization. Building on the success of the 2025 event, which attracted over 1,000 in-person participants from 600+ companies across 23 countries, this year’s forum emphasizes one-on-one meetings, non-dilutive funding opportunities, and U.S. market entry strategies.

The agenda runs across multiple days with flexible scheduling via an online networking platform, featuring:

• One-on-one meetings with strategic investors, service providers, and decision-makers.
• Networking sessions with economic development organizations, industry associations, and foreign trade partners to explore financial incentives.
• Insights into non-dilutive funding through programs like SBIR/STTR at the NIH, DoD, FDA, and NCI.
• Discussions on U.S. market validation and out-licensing to partners.

The event includes on-site promotions and in-app features for sponsors, ensuring maximum visibility and lead generation. Whether you’re an emerging biotech startup, an established MedTech firm, a service provider seeking alliances, or a government official shaping policy—MedTech World & QNova’s Annual Partnering Forum offers a curated space to connect, collaborate, and accelerate innovation in healthcare.

Benefits of Attending

• One-on-One Meetings: Connect directly with potential investors, partners, and service providers to advance your projects.
• Networking Opportunities: Engage with economic development groups, associations, and high-level government officials for incentives and collaborations.
• Funding Insights: Explore non-dilutive options through SBIR/STTR programs via NIH, DoD, FDA, NCI, and more.
• Market Strategies: Gain expertise on U.S. market validation, out-licensing, and commercialization pathways.